Home › Funds › Rosalind Advisors, Inc. › DCTH

Rosalind Advisors, Inc. position in DCTH

DELCATH SYS INC · Health Care

Rosalind Advisors, Inc. reported holding 3,300,389 shares of DCTH (DELCATH SYS INC) in its Q2 2026 13F filing — a position valued at US$41.6M, representing 15.44% of its reported portfolio and ranking #1 among its reported holdings. Rosalind Advisors, Inc. has disclosed DCTH holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

Latest position (Q2 2026)3.30M sh
Reported value held$41.55M
Portfolio Weight15.44%
First reportedQ4 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Rosalind Advisors, Inc.'s DCTH position evolved

Rosalind Advisors, Inc. first disclosed a stake in DCTH in Q4 2023 at 1,038,828 shares (US$4.3M). The position peaked in Q2 2026 at 3,300,389 shares, worth US$41.6M. Across 11 filings, Rosalind Advisors, Inc. increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 7 time(s). The most recent filing (Q2 2026) shows 3,300,389 shares valued at US$41.6M. Notable position changes include a 155% increase in Q2 2024 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2023 1.04M $4.32M New
Q1 2024 1.04M $4.96M Hold
Q2 2024 2.65M $15.53M Add
Q3 2024 2.65M $21.20M Hold
Q4 2024 2.65M $31.91M Hold
Q1 2025 2.90M $29.00M Add
Q2 2025 3.30M $33.00M Add
Q3 2025 3.30M $33.00M Hold
Q4 2025 3.30M $33.00M Hold
Q1 2026 3.30M $30.63M Hold
Q2 2026 3.30M $41.55M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DCTH and 13F data

DCTH (DELCATH SYS INC) is a Health Care company. 42 other funds we track also report a position in DCTH — the largest reported positions include Propel Bio Management, LLC (US$11.0M), Simplify Asset Management Inc. (US$3.3M), Lane Generational LLC (US$1.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DCTH

All DCTH fund holders →

FAQ

How long has Rosalind Advisors, Inc. held DCTH?

Rosalind Advisors, Inc. has disclosed DCTH holdings in 11 of the last 11 reported quarters, going back to Q4 2023.

What is Rosalind Advisors, Inc.'s current position in DCTH?

As of Q2 2026, Rosalind Advisors, Inc. holds 3.30M shares of DCTH (DELCATH SYS INC), valued at $41.55M, representing 15.44% of its reported portfolio and ranking #1.

Has Rosalind Advisors, Inc. been buying or selling DCTH?

In the latest 13F filing (Q2 2026), Rosalind Advisors, Inc. held unchanged its position in DCTH. The position peaked in Q2 2026 at 3.30M shares.

Which other funds hold DCTH?

Other major institutional holders of DCTH include Propel Bio Management, LLC, Simplify Asset Management Inc., Lane Generational LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.